OTTAWA, September 26, 2022 – Following their Annual General Meeting, BioTalent Canada has broadened its leadership team with the announcement of 16 new and returning Board Members. Under the guidance of returning Chair, Reg Joseph, CEO, Health Cities, the Board is well-positioned to support the talent within one of Canada’s most vital sectors.
The announcement of the new Board comes at a time where Canada’s bio-economy is contending with a severe talent shortage – one that could see four job openings for every job seeker by 2029.
“Despite the pandemic shining a light on how critical the bio-economy is to Canadians, employers are facing significant challenges with recruitment and retention,” says Rob Henderson, President and CEO of BioTalent Canada. “Thanks to the expertise and leadership of this new Board, BioTalent Canada is well-positioned to help the sector develop a deep pipeline of highly-skilled workers.”
Key to the addressing the talent shortage facing employers will be promoting the benefits of IDEA (Inclusivity, Diversity, Equity and Accessibility) to Canada’s bio-economy.
“Under the direction of a broadly diverse Board – representing eight provinces and multiple sub-sectors, I’m excited for the opportunity BioTalent Canada has to help employers navigate the challenges of adopting IDEA principles into the workplace.”
BioTalent Canada is pleased to announce its Board of Directors for 2022-2023:
- Reg Joseph, CEO, Health Cities, Edmonton, AB (Chair)
- Bob Golding, Consultant, Calgary, AB (Vice Chair)
- Kimberly Stephens, Vice President, Finance, High Liner Foods Incorporated, Halifax, NS (Treasurer)
- Rob Henderson, President & CEO, BioTalent Canada, Ottawa, ON (Corporate Secretary and ex-officio)
- Vivian Beer, Manager, HR Strategy, PEI BioAlliance, Charlottetown, PEI
- Alexandra Black, Director, Talent Management, SIIT, Saskatoon, SK
- Jessica Bowes, Assistant Vice President, University of Guelph, Guelph, ON
- Glenna Boyle, Director of Human Resources, Ethics and Compliance Officer, Fresenius Medical Care Canada, Toronto, ON
- Wilma Deen, Executive Director, Membership Value & Strategy Implementation, Innovative Medicines Canada (IMC), Ottawa, ON
- Jason Field, President and CEO, Life Sciences Ontario (LSO), Toronto, ON
- Allison Gaw, Principal, Amplitude Ventures, Vancouver, BC
- Charles Grubsztajn, COO, Congruence Therapeutics, Montreal, PQ
- Kim Kline, President, Bioscience Association Manitoba (BAM), Winnipeg, MB
- Chelsea Platzke, Director, Human Resources, Global Institute for Food Security (AgWest Bio), Saskatoon, SK
- Krista Schofer, Partner, Gowling WLG, Calgary, AB
- Edward Short, Vice President Human Resources, Charles River Laboratories, (BioQuebec), Montreal, P
- Dave Smardon, President & CEO, Bioenterprise Canada (Bioenterprise Canada), Guelph, ON
For more information on BioTalent Canada’s Board of Directors, visit biotalent.ca/board-directors.
About BioTalent Canada
BioTalent Canada supports the people behind life-changing science. Trusted as the go-to source for labour market intelligence, BioTalent Canada guides bio-economy stakeholders with evidence-based data and industry-driven standards. BioTalent Canada is focused on igniting the industry’s brainpower, bridging the gap between job-ready talent and employers, and ensuring the long-term agility, resiliency, and sustainability of one of Canada’s most vital sectors.
Recently named one of the 50 Best Workplaces in Canada with under 50 employees and certified as a Great Place to Work® for 2022, BioTalent Canada practices the same industry standards it recommends to its stakeholders. These distinctions were awarded to BioTalent Canada following a thorough and independent survey analysis conducted by Great Place to Work®.
For more information, visit biotalent.ca.
Vice-President, Marketing and Communications
613-235-1402 ext. 229